Search - tctmd.com

Displaying 121 - 140 of 300

Sort: Relevancy | Date

Presentation TCT 2014

Is Platelet Reactivity Testing (Genetic or Functional) Indicated/Useful in 2014?

Presenter: Laurent Bonello

September 13, 2014

News Conference News TCT 2014

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

September 13, 2014

News Conference News ESC 2014

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Yael L. Maxwell

September 03, 2014

News Daily News

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

September 02, 2014

News Conference News ESC 2014

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

Yael L. Maxwell

September 01, 2014

News Daily News

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

L.A. McKeown

August 20, 2014

News Daily News

一次性血小板检测似乎不足以指导氯吡格雷治疗的使用

July 24, 2014

News Daily News

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

July 24, 2014

News Daily News

La Prueba de la Función Plaquetaria realizada en Un Momento dado parece No Bastar para Guiar el Tratamiento con Clopidogrel

July 24, 2014

Presentation

Variability of Individual Platelet Reactivity Over Time in Patients Treated with Clopidogrel

Presenter: W. Hochholzer

July 21, 2014

Presentation

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

Presenter: Gilles Montalescot

April 11, 2014

News Daily News

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

Caitlin E. Cox

April 11, 2014

News Daily News

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Caitlin E. Cox

April 09, 2014

News Daily News

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

L.A. McKeown

March 27, 2014

News Daily News

Meta Análisis: La Alta Reactividad Plaquetaria se asocia a un Mayor Riesgo de ACV tras PCI

L.A. McKeown

March 27, 2014

Presentation

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

Presenter: Nevio Taglieri

March 25, 2014

Presentation CIT 2014

A Prospective, Randomized Trial of Chinese Medicine Tongxinluo to Attenuate High On-Treatment Platelet Reactivity in Patients After Percutaneous Coronary Intervention

Presenter: Yaling Han

March 21, 2014

News Daily News

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Yael L. Maxwell

February 13, 2014

News Daily News

Better Outcomes Seen with Prasugrel vs High-Dose Clopidogrel in Select ACS Patients

Yael L. Maxwell

January 30, 2014

News Daily News

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Caitlin E. Cox

January 29, 2014

Advertisement

Is Platelet Reactivity Testing (Genetic or Functional) Indicated/Useful in 2014?

ADAPT-DES: Stent Thrombosis Increased During First 30 Days After PCI in High-Risk Patients

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

High Reactivity on Aspirin Just Before PCI Linked to Worse Outcomes

ATLANTIC: Prehospital Ticagrelor Safe in STEMI, But No Added Benefit Compared With In-Hospital Administration

In-Hospital Switching of Antiplatelet Agents in MI Patients Relatively Common, Driven by Patient Risk, Other Factors

一次性血小板检测似乎不足以指导氯吡格雷治疗的使用

One-Time Platelet Testing Appears Insufficient to Guide Clopidogrel Therapy

La Prueba de la Función Plaquetaria realizada en Un Momento dado parece No Bastar para Guiar el Tratamiento con Clopidogrel

Variability of Individual Platelet Reactivity Over Time in Patients Treated with Clopidogrel

High On-Treatment Platelet Reactivity as a Risk Factor for Secondary Prevention After Stenting

ARCTIC Analysis: Platelet Function Testing Does Not Enhance Secondary Prevention

High Prasugrel Loading Dose Limits Platelet Reactivity after Primary PCI for STEMI

Meta-analysis: High Platelet Reactivity Linked to Increased Stroke Risk after PCI

Meta Análisis: La Alta Reactividad Plaquetaria se asocia a un Mayor Riesgo de ACV tras PCI

Risk of Stroke in Patients with High On-Clopidogrel Platelet Reactivity to Adenosine Diphosphate after PCI

A Prospective, Randomized Trial of Chinese Medicine Tongxinluo to Attenuate High On-Treatment Platelet Reactivity in Patients After Percutaneous Coronary Intervention

FDA Panel Rejects Cangrelor for Both PCI, Bridging Indications

Better Outcomes Seen with Prasugrel vs High-Dose Clopidogrel in Select ACS Patients

Ticagrelor Loading Dose May be Unnecessary for ACS Patients Previously on Clopidogrel

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content